Skip to main content
Drug bottle and Pill

Compare Viread vs. Trizivir

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tenofovir disoproxil fumarate (Viread) and Trizivir (abacavir/lamivudine/zidovudine) are both antiretroviral medications used to treat HIV. However, they belong to different medication classes and have distinct uses and characteristics. Tenofovir disoproxil fumarate (Viread) is a nucleoside reverse transcriptase inhibitor (NRTI) that is also approved for treating chronic hepatitis B, while Trizivir is a combination of three NRTIs specifically for HIV treatment. Viread is typically taken once daily, available as a tablet or powder. In contrast, Trizivir is taken twice daily and is availible as a tablet. Both medications are not a full HIV regimen on their own and should be taken with other antiretrovirals for treatment of HIV. Both are availible in generic form. Common side effects of Viread include rash, diarrhea, and headache, whereas Trizivir can cause nausea, vomiting, and headaches. Viread may interact with certain hepatitis C and HIV medications, while Trizivir requires a genetic test due to the risk of severe allergic reactions. Additionally, Viread can affect bone density and kidney function, while Trizivir is associated with blood and muscle problems.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.